I don't have a link for the replay but 2007 is on the RedChip website. (funny thing is, I think Walt is wearing the same outfit - from what I recall) the quality of the other companies is truly concerning (mostly OTC and PK) since the split i suppose SLP is basically a penny play these days. that's why I'm wondering why SLP is lumped into these other companies. Perhaps I'm just delusional. I was just reviewing some of the hERG channel predictors that SLP utilizes and this is HUGE in drug discovery. One of 2 most common reasons why drugs are pulled off the market (the other being liver toxicity). Qt prolongation and torsades the pointes is a big Black box warning. I'm not sure why this isn't picking up (contracts).
Has anyone ever watched/viewed/investigated the companies that are featured in RedChip? I watched a number of the presentations, and I would say most of them are not making money (yet/never/fill in the blank). In a way, I'm suprised SLP is even in this lineup.
Just curious what y'all think. Between the 2007 and the 2008 presentation, I have reaffirmed my confidence in the leadership.